Corrigendum to “Strengthening vaccination programmes and health systems in the European Union: A framework for action” [Health Policy 124 (2020) 511–518]

Health Policy ◽  
2020 ◽  
Vol 124 (9) ◽  
pp. 1041
Author(s):  
Luigi Siciliani ◽  
Claudia Wild ◽  
Martin McKee ◽  
Dionne Kringos ◽  
Margaret M. Barry ◽  
...  
2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
E Webb ◽  
W Palm ◽  
E van Ginneken ◽  
S Lessof ◽  
L Siciliani ◽  
...  

Abstract Background At the request of the European Commission, the Observatory on Health Systems and Policies and the HSPM network have undertaken a study to explore gaps in universal health coverage in the European Union and increase the level of granularity in terms of areas or groups where accessibility is sub-optimal. Methods To explore these gaps more systematically a survey was developed based on the so-called cube model that comprises different dimensions determining health coverage, including population coverage, service coverage and cost coverage. In addition, access can also be hampered by other factors, which relate more to the physical availability of care, a person's ability to obtain necessary care or the attitude of the provider. The survey was sent to country contacts from the Health Systems and Policy Monitor network. Results Within the diversity of country cases found in the survey, the most significant barriers for accessing health care still seem to be associated with social and income status, rather than specific medical conditions. However, groups like mentally ill, homeless, frail elderly, undocumented migrants are more likely to face multiple layers of exclusion and complex barriers to access. Conclusions Health system interventions can close access gaps for these vulnerable groups and address inequities in access to care. Through detailed coverage design countries can indeed determine the extent to which financial hardship and catastrophic out-of-pocket spending can be prevented. Furthermore, scope exists to improve current data collection practice.


2020 ◽  
Vol 18 (4) ◽  
pp. 9-26
Author(s):  
Paweł Turczyński ◽  

The coronavirus pandemic that hit the world in early 2020 has weakened Europe very severely. In the first period (January-February), the disease was often neglected, which allowed it to spread rapidly. In March, panic struck European societies, the health systems of many countries collapsed, and governments introduced drastic restrictions on civil liberties and on the functioning of the economy. The European Union, which was helpless in the first period, took steps in the spring to restore the European economy after the end of the epidemic.


2017 ◽  
Vol 27 (5) ◽  
pp. 792-793 ◽  
Author(s):  
Natasha Azzopardi-Muscat ◽  
Katarzyna Czabanowska ◽  
Nicoline Tamsma ◽  
Archie Turnbull

2015 ◽  
Vol 8 (1) ◽  
pp. 77-83
Author(s):  
Eva Turk ◽  
Stephen Leyshon ◽  
Morten Pytte

Patient safety is a right and it raises particular issues in the context of cross-border care. Patients should be able to have trust and confidence in the healthcare structure as a whole; they must be protected from the harm caused by poorly functioning health systems, medical errors and adverse events. This paper addresses the state of cross-border healthcare in the European Union, the state of patient safety, the question of quality assurance and the role of accreditation as a risk based approach.


2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  

Abstract Objective The EU is often criticized for being ‘market-driven’ and practicing a form of ‘cold integration’. Any attempt, however, to strengthen solidarity and social integration in the EU is met by stakeholders in the member states with reservation and often outright refusal, arguing that health systems are national competence subject to the subsidiary principle. This conundrum of asking for more but allowing for less has blocked a scientifically informed public debate about the EU and health policy. The overall objective of this workshop is to discuss how health research can contribute to resolve this conundrum making the EU more conducive to the needs of health systems, public health (PH) and Health in All Policies (HiAP). To this end we will review the following 4 specific topics What are is EU-health policy and what other policies are affecting health and health systems?What tells us the projected Brexit-impact on the UK health system and PH about the value of EU health policy?Are EU-trade policies shaping healthier commercial determinants of health?What is the added value of cross-border care at and beyond border regions? This workshop is based on the update of the seminal volume “Everything you always wanted to know about European Union health policies but were afraid to ask” (2019, 2nd edition). Key note Scott Greer: In health and health systems the European Union is ubiquitous. Health systems in Europe are hard to figure without the cross border mobility of health professions. Patients going cross-borders. We have a European Medicines Agency that is regulating key aspects of the pharmaceutical market. Health systems have become part of the economic governance of the EU. In PH we have the ECDC, a PH programme and policies on health related consumer protection and may mechanism that should protect European citizens from scourges that know no borders. With health in all policies, the EU legislates literally on all known agents and, when in doubt, is using the pre-cautionary principle to protect citizens from health hazards. All this is supported by a large EU research programme. Panellist 1 N Fahy, the projected impact of Brexit on health system functions of the United Kingdom demonstrates how deep the integration goes and how beneficial it is for both health systems and public health. Panellist 2 H Jarman: The discussion around the Transatlantic Trade an Investment Partnership (TTIP) have risen worries about privatization of health services and lowering of food standards. But TTIP is only the tip of the Iceberg given that the EU has several types of trade agreements with many countries and groups of countries, shaping the commercial determinants of health. Panellist 3 W Palm: Cross-border collaboration is already taking place in many border regions. The European reference networks demonstrate the value of the cross-border collaboration beyond border regions, as does collaboration for joint purchasing and health workforce development. Key messages Health is important at the EU level and the EU level is important for health. Not shaping health and health systems at EU level will limit the perspectives of EU integration, health system development public health and HiAP. Panelists Scott Greer Holly Jarman Contact: [email protected] Nick Fahy Contact: [email protected] Willy Palm Contact: [email protected] Contact: [email protected]


Health Policy ◽  
2020 ◽  
Vol 124 (5) ◽  
pp. 511-518 ◽  
Author(s):  
Luigi Siciliani ◽  
Claudia Wild ◽  
Martin McKee ◽  
Dionne Kringos ◽  
Margaret M. Barry ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document